CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447,969 | +35.0% | 15,206 | +49.5% | 0.00% | +100.0% |
| Q2 2023 | $331,778 | -7.5% | 10,171 | -0.2% | 0.00% | -50.0% |
| Q1 2023 | $358,551 | -28.1% | 10,189 | -6.3% | 0.00% | -33.3% |
| Q4 2022 | $498,339 | +146.7% | 10,876 | +160.4% | 0.00% | +200.0% |
| Q3 2022 | $202,000 | +32.9% | 4,177 | +7.8% | 0.00% | 0.0% |
| Q2 2022 | $152,000 | +5.6% | 3,873 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | +45.5% | 3,910 | +79.8% | 0.00% | 0.0% |
| Q4 2021 | $99,000 | +28.6% | 2,175 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $77,000 | +83.3% | 2,157 | +2.0% | 0.00% | – |
| Q2 2021 | $42,000 | -16.0% | 2,114 | -0.8% | 0.00% | -100.0% |
| Q1 2021 | $50,000 | +1566.7% | 2,131 | +1422.1% | 0.00% | – |
| Q4 2020 | $3,000 | -66.7% | 140 | -65.0% | 0.00% | – |
| Q3 2020 | $9,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |